CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 146 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $565,538 | +20.5% | 48,378 | +71.0% | 0.00% | 0.0% |
| Q2 2023 | $469,180 | 0.0% | 28,298 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $469,180 | +114.2% | 28,298 | +65.5% | 0.00% | +200.0% |
| Q3 2022 | $219,000 | +79.5% | 17,101 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $122,000 | -33.7% | 17,499 | -21.5% | 0.00% | 0.0% |
| Q1 2022 | $184,000 | +22.7% | 22,301 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $150,000 | +28.2% | 22,301 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $117,000 | +1571.4% | 22,301 | +823.8% | 0.00% | – |
| Q3 2020 | $7,000 | +133.3% | 2,414 | +189.1% | 0.00% | – |
| Q2 2020 | $3,000 | – | 835 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |